The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Santos David A since 2023.
This trader's CIK number is 1820066.
At the time of last reporting, Santos David A was the EVP, Chief Commercial Officer of Rigel Pharmaceuticals Inc. (stock ticker symbol RIGL).
Also see all insider trading activities at Rigel Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RIGL | 0 | $0 | 3,921 | $83,836 | 0 | $0 |
| 2024 | RIGL | 0 | $0 | 14,519 | $16,495 | 0 | $0 |
| 2023 | RIGL | 0 | $0 | 5,388 | $8,944 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-05 | RIGL | Sale | 1,796 | 21.93 | 39,379 |
| 2025-02-04 | RIGL | Sale | 2,125 | 20.92 | 44,457 |
| 2024-02-05 | RIGL | Sale | 8,918 | 1.14 | 10,166 |
| 2024-02-02 | RIGL | Sale | 5,601 | 1.13 | 6,329 |
| 2023-02-02 | RIGL | Sale | 5,388 | 1.66 | 8,944 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Santos David A (EVP, Chief Commercial Officer of Rigel Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.